Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Harrow (HROW) EBITDA (2016 - 2025)

Historic EBITDA for Harrow (HROW) over the last 13 years, with Q3 2025 value amounting to $14.7 million.

  • Harrow's EBITDA rose 101635.12% to $14.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.8 million, marking a year-over-year increase of 41080.21%. This contributed to the annual value of $8.8 million for FY2024, which is 194686.77% up from last year.
  • Latest data reveals that Harrow reported EBITDA of $14.7 million as of Q3 2025, which was up 101635.12% from $11.4 million recorded in Q2 2025.
  • In the past 5 years, Harrow's EBITDA registered a high of $14.7 million during Q3 2025, and its lowest value of -$11.2 million during Q1 2025.
  • Moreover, its 5-year median value for EBITDA was $1.5 million (2024), whereas its average is $1.5 million.
  • Its EBITDA has fluctuated over the past 5 years, first soared by 195531.91% in 2023, then tumbled by 67256.2% in 2024.
  • Quarter analysis of 5 years shows Harrow's EBITDA stood at -$1.8 million in 2021, then dropped by 1.31% to -$1.8 million in 2022, then crashed by 174.18% to -$4.9 million in 2023, then soared by 364.59% to $12.9 million in 2024, then rose by 14.33% to $14.7 million in 2025.
  • Its EBITDA was $14.7 million in Q3 2025, compared to $11.4 million in Q2 2025 and -$11.2 million in Q1 2025.